PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 31678537-6 2020 Cumulative incidence of VOD/SOS at day 50 was 3.1% after RIC regimen with Flu/Bu2+-ATG (busulfan dose 6.4 mg/kg), compared to 0.15% after Flu/Bu1+-ATG (busulfan dose 3.2 mg/kg) (p=0.0002); the incidence rate was 2.1% after RIC HCT with sirolimus containing GVHD prophylaxis, compared to 0.8% for RIC without sirolimus (p=0.06). Busulfan 88-96 xylosyltransferase 2 Homo sapiens 28-31 24174393-6 2014 RESULT: In patients receiving Bu four times per day Bu levels >1,500 micromol/L minute correlate to an increased risk of developing a SOS. Busulfan 30-32 xylosyltransferase 2 Homo sapiens 137-140 24174393-6 2014 RESULT: In patients receiving Bu four times per day Bu levels >1,500 micromol/L minute correlate to an increased risk of developing a SOS. Busulfan 52-54 xylosyltransferase 2 Homo sapiens 137-140